問卷
此案目前為暫存狀態
編修至YYYY/MM/DD
不開放編輯功能
Find Division/Department
National Taiwan University Hospital
All Location
All Division/Department
篩選
Developmental Phase
Phase I
Phase I/II
Phase II
Phase II/III
Phase III
Phase IV
Others
Trial Status
Not yet recruiting
Active
Completed
Recruitment Status
Recruiting
Terminated
Stop recruiting
Suspended
Study ended
Trial scale
Multi-Regional Multi-Center
Taiwan Multiple Center
Taiwan Single Center
The expected start time interval of the test
Trial Applicant
Hospital/Foundation
Pharmaceutical/Biopharmaceutical company
Contract Research Organization
Important Roles
Asia Regional PI
Taiwan National PI
Chairman/Global PI
Steering Committee
Advisory board
None
Audit by Sponsors/CRO
Sponsors
CRO
Investigator-initiated trial(IIT)
Yes
Filters
下載
2024-09-02 - 2027-12-31
Condition/Disease
Test Drug
Participate Sites3Sites
Recruiting3Sites
2021-09-30 - 2030-04-04
Newly Diagnosed Philadelphia (Ph)-Negative B-cell Precursor Acute Lymphoblastic Leukemia (ALL)
BLINCYTO for Injection
Participate Sites5Sites
Recruiting5Sites
2021-08-02 - 2026-09-18
Participate Sites2Sites
Recruiting2Sites
2021-09-02 - 2026-05-25
Participate Sites6Sites
Recruiting6Sites
2022-01-01 - 2025-08-18
Division of Infectious Disease
2021-11-01 - 2022-08-29
2021-11-01 - 2024-07-31
2021-05-03 - 2022-07-07
2022-01-03 - 2023-12-31
Participate Sites4Sites
Recruiting4Sites
2021-11-03 - 2025-08-25
全部
